You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
25 June 2019
GlaxoSmithKline (GSK) appears to have offered concessions to the European Commission as it seeks approval for its proposed consumer healthcare joint venture with Pfizer. Meanwhile, media reports suggest GSK has started a sale process for three portfolios of consumer healthcare products with a combin...
10 June 2019
Stada Arzneimittel is acquiring a portfolio of OTC brands, including Oilatum and Savlon Antiseptic Cream, from GlaxoSmithKline Consumer Healthcare for an undisclosed sum.
13 May 2019
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 1% at constant exchange rates in the first quarter of 2019. The company's shareholders have just approved the proposed consumer healthcare joint venture with Pfizer.
8 May 2019
Crown Laboratories has boosted its skincare offering in North America by acquiring the Keri brand from GlaxoSmithKline (GSK) for an undisclosed sum.
5 March 2019
The planned joint venture between GlaxoSmithKline (GSK) and Pfizer is the winner of the 2019 OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.
22 January 2019
GlaxoSmithKline (GSK), Galenica, Almirall and the US Council for Responsible Nutrition (CRN) have all recently announced people changes.
19 December 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses into a "world-leading" joint venture with combined annual sales of around GBP9.8 billion (USD12.7 billion).
3 December 2018
Unilever is acquiring a portfolio of consumer healthcare nutrition products, including Horlicks, from GlaxoSmithKline (GSK) in a deal worth EUR3.3 billion (USD3.8 billion).
3 December 2018
Crown Laboratories has boosted its skincare offering in North America by acquiring five brands from GlaxoSmithKline Consumer Healthcare for an undisclosed sum.
9 November 2018
Worldwide sales at GlaxoSmithKline's Consumer Healthcare business increased by 3% at constant exchange rates in the third quarter of 2018, as sales declined in Europe but grew in the US and International markets.